Funds and ETFs Sinocelltech Group Limited

688520

CNE100003ZL3

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
49.84 ^CNY	+1.10%		+0.18%	-7.48%

25/04	Sinocelltech Group Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/04	Sinocelltech Forecasts Return to Profit in Q1	MT

ETFs positioned on Sinocelltech Group Limited

Name	Weight	AuM	1st Jan change	Investor Rating
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	0.00%	34 M€	+2.67%	-

Sinocelltech Group Ltd is a China-based company mainly engaged in the research, development and industrialization of biopharmaceutical products. The Company focuses on monoclonal antibodies, recombinant proteins and vaccine products. Its main products are SCT800, SCT200, SCT-I10A, SCT400, SCT510, SCT1000 and SCT630, among others. The Company is also engaged in asset leasing business and payment collection business.

Sector

Biotechnology & Medical Research

Calendar

21/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Sinocelltech Group Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

49.84 CNY

Average target price

69 CNY

Spread / Average Target

+38.44%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
SINOCELLTECH GROUP LIMITED	-7.48%	3.07B
REGENERON PHARMACEUTICALS, INC.	+8.96%	105B
VERTEX PHARMACEUTICALS INCORPORATED	-1.43%	104B
ARGENX SE	+4.40%	22.94B
BIONTECH SE	-12.15%	22.34B
GENMAB A/S	-4.36%	19.25B
WUXI APPTEC CO., LTD.	-39.98%	17.08B
BEIGENE, LTD.	-10.04%	16.96B
NEUROCRINE BIOSCIENCES, INC.	+6.79%	14.16B
SAREPTA THERAPEUTICS, INC.	+38.61%	12.63B